Cell lineage and differentiation state are primary determinants of mycn gene expression and malignant potential in human neuroblastoma cells

Oncology Research

Volumn 9, Issue 9, 1997, Pages 467-476

  Spengler, Barbara A ^a   Lazarova, Darina L ^a   Ross, Robert A ^b   Biedler, June L ^b  

^a FORDHAM UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Differentiation; Human neuroblastoma; Malignant potential; Mycn regulation

Indexed keywords

DNA; MYC PROTEIN; RNA; TUMOR PROTEIN;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; NEUROBLASTOMA; NUDE MOUSE; ONCOGENE MYC; PATHOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0031297303     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Biedler, J. L.; Helson, L.; Spengler, B. A. Morphology and growth, tumorigeniciiy, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:2643-2652;1973.
2. Tumilowicz, J. J.; Nichols, W. W.; Cholon, J. J.; Greene, A. E. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res. 30:2110-2118; 1970.
3. Biedler, J. L.; Roffler-Tarlov, S.; Schachner, M.; Freedman, L. S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38:3751-3757; 1978.
4. Biedler, J. L.; Spengler, B. A.; Ross, R. A. Chromosomal and biochemical properties of human neuroblastoma lines and clones in cell culture. Gaslini 11:128-139; 1979.
5. Ross, R. A.; Job, T. H.; Reis, D. J.; Spengler, B. A.; Biedler, J. L. Neurotransmitter-synthesizing enzymes in human neuroblastoma cells: Relationship to morphological diversity. In: Evans, A. E., ed. Advances in neuroblastoma research. New York: Raven Press; 1980:151-160.
6. Ross, R. A.; Spengler, B. A.; Biedler, J. L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 71:741-747; 1983.
7. Ross, R. A. Biedler, J. L. Expression of a melanocyte phenotype in human neuroblastoma cells in vitro. In: Evans, A. E.; D'Angio, G. J.; Seeger, R. C., eds. Advances in neuroblastoma research. New York: Alan R. Liss, Inc.; 1985:249-259.
8. Ross, R. A.; Biedler, J. L. Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro. Cancer Res. 45:1628-1632; 1985.
9. Tsokos, M.; Scarpa, S.; Ross, R. A.; Triche, T. J. Differentiation of human neuroblastoma recapitulates neural crest development. Am. J. Pathol. 128:484-493; 1987.
10. Rettig, W. J.; Spengler, B. A.; Garin Chesa, P.; Old, L. J.; Biedler, J. L. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res. 47:1383-1389; 1987.
11. Sadée, W.; Yu, V. C.; Richards, M. L.; Preis, P. N.; Schwab, M. R.; Brodsky, F. M.; Biedler, J. L. Expression of neurotransmitter receptors and myc proto-oncogenes in subclones of a human neuroblastoma cell line. Cancer Res. 47:52075212; 1987.
12. DeClerck, Y. A.; Bomann, E. T.; Spengler, B. A.; Biedler, J. L. Differential collagen biosynthesis by human neuroblastoma cell variants. Cancer Res. 47:6505-6510; 1987.
13. Ciccarone, V.; Spengler, B. A.; Meyers, M. B.; Biedler, J. L.; Ross, R. A. Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineages. Cancer Res. 49:219-225; 1989.
14. Ross, R. A.; Bossart, E.; Spengler, B. A.; Biedler, J. L. Multipotent capacity of morphologically intermediate (I-type) human neuroblastoma cells after treatment with differentiationinducing drugs. In: Evans, A. E.; D'Angio, G. J.; Knudson, A. G., Jr.; Seeger, R. C., eds. Advances in neuroblastoma research 3. New York: Wiley-Liss; 1991:193-201.
15. Ross, R. A.; Spengler, B. A.; Domènech, C.; Porubcin, M.; Rettig, W. J.; Biedler, J. L. Human neuroblastoma 1-type cells are malignant neural crest stem cells. Cell Growth Differ. 6:449-456; 1995.
16. Biedler, J. L.; Spengler, B. A.; Ross, R. A. Human neuroblastoma cell differentiation. In: Raghavan, D.; Scher, H. L.; Leibel, S. A.; Lange, P., eds. Principles and practice of genitourinary oncology. Philadelphia, PA: Lippincott-Raven Publishers; 1997:1053-1061.
17. Stemple, D. L.; Anderson, D. J. Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 71: 973-985; 1992.
18. Anderson, D. J. Stem cells and transcription factors in development of the mammalian neural crest. FASEB J. 8:707-713; 1994.
19. Ciment, G. The melanocyte/Schwann cell progenitor: A bipolent intermediate in the neural crest lineage. Commun. Dev. Neurol. 1:207-223; 1990.
20. Brodeur, G. M.; Seeger, R. C.; Schwab, M.; Varmus, H. E.; Bishop, J. M. Amplification of N-wyc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124; 1984.
21. Seeger, R. C.; Brodeur, G. M.; Sather, H.; Dalton, A.; Siegel, S. E.; Wong, K. Y.; Hammond, D. Association of multiple copies of the N-wyc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313:1111-1116; 1985.
22. Small, M. B.; Hay, N.; Schwab, M.; Bishop, J. M. Neoplastic transformation by the human gene N-inyc. Mol. Cell. Biol. 7: 1638-1645; 1987.
23. Schwab, M.; Bishop, J. M. Sustained expression of the human proto-oncogene MYCN rescues rat embryo cells from senescence. Proc. Natl. Acad. Sei. USA 85:9585-9589; 1988.
24. Weiss, W. A.; Aldape, K.; Mohapatra, G.; Feuerstein, B. G.; Bishop, J. M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16:2985-2995; 1997.
25. Zimmerman, K. A.; Yancopoulos, G. D.; Collum, R. G.; Smith, R. K.; Kohl, N. E.; Denis, K. A.; Nau, M. M.; Witte, O. N.; Toran-Allerand, D.; Gee, C. E.; Minna, J. D.; Alt, F. \V. Differential expression of myc family genes during murine development. Nature 319:780-783; 1986.
26. Grady, E. F.; Schwab, M.; Rosenau, W. Expression of N-inyc and c-src during the development of fetal human brain. Cancer Res. 47:2931-2936; 1987.
27. Mugrauer, G.; Alt, F. \V.; Ekblom, P. N-inycproto-oncogene expression during organogenesis in the developing mouse as revealed by in situ hybridization. J. Cell Biol. 107:1325-1335; 1988.
28. Hirning, U.; Schmid, P.; Schulz, W. A.; Rettenberger, G.; Hameister, H. A comparative analysis of N-myc and c-inyc expression and cellular proliferation in mouse organogenesis. Mech. Dev. 33:119-126; 1991.
29. Stanton, B. R.; Perkins, A. S.; Tessarollo, L.; Sassoon, D. A.; Parada, L. F. Loss of N-rnyc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 6:2235-2247; 1992.
30. Charron, J.; Malynn, B. A.; Fisher, P.; Stewart, V.; Jeannotte, L.; Goff, S. P.; Robertson, E. J.; Alt, F. \V. Embryonic lethality in mice homozygous for a targeted disruption of the N-mycgene. Genes Dev. 6:2248-2257, 1992.
31. Seeger, R. C.; Rayner, S. A.; Banerjee, A.; Chung, H.; Laug, W. E.; Neustein, H. B.; Benedict, W. F. Morphology, growth, chromosomal pattern, and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res. 37:13641371; 1977.
32. Reynolds, C. P.; Biedler, J. L.; Spengler, B. A.; Reynolds, D. A.; Ross, R. A.; Frankel, E. P.; Smith, R. G. Characterization of human neuroblastoma cell lines established before and after therapy. J. Natl. Cancer Inst. 76:375-387; 1986.
33. Schlesinger, H. R.; Rorke, L.; Jamieson, R.; Hummeler, K. Neuronal properties of neuroectodermal tumors in vitro. Cancer Res. 41:2573-2575; 1981.
34. Farrell, R. E., Jr. Methodologies for RNA characterization 1: The isolation and characterization of mammalian RNA. Clin. Biotechnol. 1:50-58; 1989.
35. Feinberg, A. P.; Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity [Addendum]. Anal. Biochem. 137:266-267; 1984.
36. Michitsch, R. W.; Biedler, J. L.; Mêlera, P. W. Modulation of N-myc expression, but not tumorigenicity, accompanies phenotypic conversion of neuroblastoma cells in prolonged culture. In: Evans, A. E.; D'Angio, G. J.; Knudson, A. G.; Seeger, R. C., eds. Advances in neuroblastoma research 2. New York: Alan R. Liss, Inc.; 1988:103-120.
37. Ikegaki. N.; Bukovsky, J.; Kenne, R. H. Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. Proc. Natl. Acad. Sei. USA 83:5929-5933; 1986.
38. Rubin, B. Y.; Anderson, S. L.; Xing, L.; Powell, R. J.; Tale, W. P. Interferon induces Iryptophanyl-tRNA synthetase expression in human fibroblasts. J. Biol. Chem. 266:2424524248;1991.
39. Macpherson, I. Soft agar techniques. In: Kruse, P. F., Jr.; Patterson, M. K., Jr., eds. Tissue culture, methods and applications. New York: Academic Press, Inc.; 1973:276-280.
40. Biedler, J. L.; Meyers, M. B.; Spengler, B. A. Homogeneously staining regions and double minute chromosomes, prevalent cytogenetic abnormalities of human neuroblastoma cells. In: Federoff, S.; Hertz, L., eds. Advances in cellular neurobiology, vol. 4. New York: Academic Press; 1983:267-307.
41. Biedler, J. L.; Spengler, B. A.; Chang, T.-d.; Ross, R. A. Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. In: Evans, A. E.; D'Angio, G. J.; Knudson, A. G.; Seeger, R. C., eds. Advances in neuroblastoma research 2. New York: Alan R. Liss, Inc.; 1988:265-276.
42. Spengler, B. A.; Dominech, C.; Porubcin, M.; Biedler, J. L. Human neuroblastoma lines respond differently to diverse differentiation-inducing agents. In: Evans, A. E.; Biedler, J. L.; Brodeur, G. M.; D'Angio, G. J.; Nakagawara, A., eds. Advances in neuroblastoma research 4. New York: WileyLiss, Inc.; 1994:261-267.
43. Thiele, C. J.; Reynolds, C. P.; Israel, M. A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313:404406;1985.
44. Foley, J.; Cohn, S. L.; Salwen, H. R.; Chagnovich, D.; Cowan, J.; Mason, K. L.; Parysek, L. M. Differential expression of ti-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res. 51:6338-6345; 1991.
45. Dimitroulakos, J.; Squire, J.; Pawlin, G.; Yeger, H. NUB-7: A stable I-type human neuroblastoma cell line inducible along N- and S-type cell lineages. Cell Growth Differ. 5:373-384; 1994.
46. Sugimoto, T.; Kalo, T.; Sawada, T.; Horii, Y.; Kemshead, J. T.; Hino, T.; Morioka, H.; Hosoi, H. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine. Cancer Res. 48:2531-2537; 1988.
47. Horii, Y.; Sugimoto, T.; Sawada, T.; Imanishi, J.; Tsuboi, K.; Hatanaka, M. Differential expression of N-myc and c-src proto-oncogenes during neuronal and schwannian cell differentiation of human neuroblastoma cells. Int. J. Cancer 43: 305-309; 1989.
48. Sano, K.; Motoike, T.; Nakamura, H.; Matsui, Y.; Teranishi, Y.; Takai, Y. Differential expression of the N-niyc, c-fos, and smg p25A genes in human neuroblastoma cells during neuronal and schwannian differentiation. Mol. Brain Res. 9: 149-152; 1991.
49. Matsushima, H. Bogenmann, E. Di-modal differentiation pattern in a new human neuroblastoma cell line in vitro. Int. J. Cancer 51:250-258; 1992.
50. Amatruda, T. T.; Sidell, N.; Ranyard, J.; Koeffler, H. P. Retinoic acid treatment of human neuroblastoma cells is associated with decreased N-myc expression. Biochem. Biophys. Res. Commun. 126:1189-1195; 1985.
51. Israel, M. A.; Thiele, C. J. Regulation of N-myc is a critical event controlling the ability of human neuroblastoma cells to differentiate. Exp. Cell Biol. 56:321-333; 1988.
52. Schweigerer, L.; Breit, S.; Wenzel, A.; Tsunamoto, K.; Ludwig, R.; Schwab, M. Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: Evidence for induction of autocrine growth factor activity. Cancer Res. 50:4411-4416; 1990.
53. Brondyk, W. H.; Bosckman, F. A.; Fahl, W. F. N-niyc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize. Oncogene 6:1269-1276; 1991.
54. Gross, N.; Miescher, G.; Beck, D.; Favre, S.; Beretta, C. Altered growth and phenotype in clonal niycN transfectants of the SK-N-SH neuroblastoma cell line. Int. J. Cancer 59: 141-148; 1994.
55. Negroni, A.; Scarpa, S.; Romeo, A.; Ferrari, S.; Modesti, A.; Raschella, G. Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ. 2:511-518; 1991.
56. Sleight, B. J.; Soukup, S.; Ballard, E. T.; Parysek, L. M. S-cells from a highly N-wyc-amplified neuroblastoma are tumorigenic in nude mice. Anticancer Res. 13:2031-2036; 1993.
57. Schmidt, M. L.; Salwen, H. R.; Manohar, C. F.; Ikegaki, N.; Cohn, S. L. The biological effects of antisense N-myc expression in human neuroblastoma. Cell Growth Differ. 5: 171-178; 1994.
58. Nisen, P. D.; Waber, P. G.; Rich, M. A.; Pierce, S.; Garvin, J. R., Jr.; Gilbert, F.; Lanzkowsky, P. N-myc oncogene RNA expression in neuroblastoma. J. Nail. Cancer Inst. 80:1633-1637;1988.
59. Slave, I.; Ellenbogen, R.; Jung, H.-I.; Vawter, G. F.; Kretschmar, C.; Grier, H.; Korf, B. R. inyc gene amplification and expression in primary human neuroblastoma. Cancer Res. 50: 1459-1463; 1990.
60. Biedler, J. L.; Chang, T.-d.; Peterson, R. H. F.; Mêlera, P. W.; Meyers, M. B.; Spengler, B. A. Gene amplification and phenotypic instability in drug-resistant and revenant cells. In: Chabner, B. A., ed. Rational basis for chemotherapy. New York: Alan R. Liss, Inc.; 1983:71-92.
61. Chagnovich, D.; Cohn, S. L. Binding of a 40 kDa protein to the N-myc 3'-untranslated region correlates with enhanced N-iiyr expression in human neuroblastoma. J. Biol. Chem. 271:33580-33586:1996.
62. Ross, R. A.; Lazarova, D. L.; Manley, G. T.; Smitt, P. S.; Spengler, B. A.; Posner, J. B.; Biedler, J. L. HuD, a neuronal-specific RNA-binding protein, is a potential regulator of A/VCWexpression in human neuroblastoma cells. Proceedings of advances in neuroblastoma research 1996. Eur. J. Cancer (in press).
63. Lazarova, D.; Manley, G.; Smitt, P. S.; Spengler, B. A.; Biedler, J. L.; Posner, J. B.; Ross, R. A. Site specificity of interaction between HuD, a neuronal-specific RNA-binding protein, and the 3'-UTR of human MYCN mRNA. Proc. Am. Assoc. Cancer Res. 37:578; 1996.
64. Chagnovich, D.; Fayos, B. E.; Cohn, S. L. Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma. J. Biol. Chem. 271:33587-33591; 1996.
65. Brodeur, G. M. Genetics of embryonal tumours of childhood: Retinoblastoma, Wilms' tumour and neuroblastoma. In: Cancer surveys vol. 25: Genetics and cancer: A second look. London: Imperial Cancer Research Fund; 1995:67-99.